Janux Therapeutics, Inc. - JANX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 6.9% 4,196,409 View
May 12, 2026 SCHEDULE 13G STATE STREET CORPORATION 4.1% 2,464,017 View
May 06, 2026 SCHEDULE 13G/A FMR LLC 4.2% 2,535,724 View
May 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 4.2% 2,535,724 View
Apr 29, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Steven A. Cohen 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.0% 3,069,759 View
Apr 29, 2026 SCHEDULE 13G Steven A. Cohen 5.0% 3,069,759 View
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 8.9% 5,350,453 View
Feb 06, 2026 SCHEDULE 13G Prosight Management, LP 5.2% 3,150,970 View
Feb 06, 2026 SCHEDULE 13G Prosight Fund, LP 0.2% 148,416 View
Feb 06, 2026 SCHEDULE 13G Prosight Plus Fund, LP 1.1% 685,220 View
Feb 06, 2026 SCHEDULE 13G Prosight Partners, LLC 5.2% 3,150,970 View
Feb 06, 2026 SCHEDULE 13G W. Lawrence Hawkins 5.3% 3,157,220 View
Jan 08, 2026 SCHEDULE 13G/A FMR LLC 5.8% 3,512,384 View
Jan 08, 2026 SCHEDULE 13G/A Abigail P. Johnson 5.8% 3,512,384 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.